The 1st Congress of the Israeli Society Translational Medicine (ISTM)
September 29,2025
Sami Ofer Auditorium, Sourasky Medical Center (Ichilov), Tel-Aviv
Chairs: Ygal Shoshan, Dror Mevorach
On September 29, 2025, a one-day founding conference of the organization will be held at the Tel Aviv Sourasky Medical Center, dedicated to new research technologies, presentations of examples of scientific-medical collaboration, and short talks by researchers in Israel working in translational medicine.
| Monday, September 29, 2025 | |
|---|---|
| 08:30-09:00 | Registration, gathering and morning coffee |
| 09:00 | Dror Mevorach, ISTM President: Welcome, Aims & missions of ISTM |
| 09:10-10:20 | Session 1: “Understandomics” |
| 09:10-09:40 | Hadas Keren-Shaul, PhD, Head of the Crown Institute for Genomics, INCPM, Head of the Sandbox Genomics, LSCF, Weizmann Institute of Science: Next-Generation Technologies Transforming Single-Cell Multiomics and Spatial Transcriptomics |
| 09:40-10:20 | Plenary lecture: Shalev Itzkovitz, PhD, Department of Molecular Cell Biology, Weizmann Institute of Science: Celiac Disease: Understanding the disease via spatial transcriptomics |
| 10:20-11:20 | Session 2: From the Clinics to the Bench and Back |
| 10:20-10:40 | Dror Mevorach, MD, Hadassah University Hospital and Medical School: Deciphering the pathogenesis of recurrent Guillain-Barré Syndrome paves the way for life-saving treatments |
| 10:40-11:00 | Chen Varol, PhD, The Research Center for Digestive Tract & Liver Diseases, Tel-Aviv Sourasky Medical Center: Glucose-dependent Insulinotropic polypeptide (GIP) is a Gut-Derived Immune modulator bridging metabolic and Immune pathways in obesity |
| 11:00-11:20 | Adi Zoref Lorenz, MD, Meir Hospital: HLH in hematologic malignancies: From Bedside to Bench and back |
| 11:20-11:45 | Coffee break |
| 11:45-13:25 | Session 3: Translational Medicine in Israel: Short presentations from abstracts |
| 11:40-11:55 | Spatial transcriptomics identifies the specific signature of myofibroblasts within fibroblastic foci in idiopathic pulmonary fibrosis Yan Stein, Ophir Freund, Doron Cohn-Schwartz, Sarah Borsekofsky, Liran Levy, Amir Bar-Shai , Naftali Kaminski , Avraham Unterman Genomic Research Laboratory for Lung Fibrosis, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel, Institute of Pulmonary Medicine, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel, Institute of Pathology, Tel Aviv Medical Center, Tel Aviv, Israel, Institute of Pulmonary Medicine, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel. Section of Pulmonary, Critical Care, and Sleep Medicine, Yale University, New Haven, CT |
| 11:55-12:10 | Rapid, Point-of Care DNA Methylation and Molecular Landscape Based Sarcoma Classification Myriam Maoz, Boaz Ben-Kuzari, Daniel Burg Omer Or, Noam Olshinkaa, Jonathan Abraham Demma, Meni Brakha, Gilad W. Vainer, Galina Feinberg, Yehudit Birger, Assaf Grunwald, Orly Michaeli, Shirah Amar, Alaa Darwish, Amir Eden & Aviad Zick Oncology Department, Orthopedic Department, Surgical Department, Pathology Department, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel, and Hemato-Oncology Laboratory, Schneider Children’s Medical Center of Israel, Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Israel.- Felsenstein Medical Research Center, Tel Aviv University, Israel, Department of Genetics, The Hebrew University of Jerusalem, Jerusalem |
| 12:10-12:25 | Pin1-Mediated Alternative Splicing Dysregulation Drives Cystogenesis in Tuberous Sclerosis Complex Through mTORC1-Independent Mechanism Varshavsky, Eden Abergel, Yuval Nevo, Inbar Plaschkes, Yishai Levin, Shulamit Wallach-Dayan, Iddo Z. Ben-Dov, Morris Nechama, Oded Volovelsky Pediatric Nephrology Unit, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem |
| 12:25-12:40 | Balancing immune-related adverse events: glucocorticoids combined with immune checkpoint inhibitors promote LAG-3 expression Smadar Gertel, Ari Polachek, Victoria Furer, Tali Ofir Dovrat, Chen Avaky, Adi Broyde, Hila Nochimovitz and Ori Elkayam Department of Rheumatology, Tel-Aviv Sourasky Medical Center and Tel-Aviv University, Tel-Aviv, Israel |
| 12:40-12:55 | Characterization of Urinary Bacterial Strain Diversity in Relation to Bladder Cancer Aggressiveness Omri Nativ, Haitham Hajjo, Tal Gefen, Azik Hoffman, Gilad Amiel¹ Shaqed Carasso, Naama Geva Zatorsky Department of Urology, Rambam Health Care Campus, Haifa, Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Technion Integrated Cancer Center (TICC), Haifa |
| 12:55-13:10 | Metabolic nuclear sequestration of the proteasome as Achilles heel of tumor growth: A platform for development of patient-specific management and treatment modalities Ido Livne, MD/PhD, Department of Pathology, Rambam and Technion, Haifa |
| 13:10-13:25 | Deciphering Kidney Development and Disease with Human Organoid Models: Insights from RAAS-Deficient Organoids and Beyond Naomi Pode Shakked, MD, PhD, Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel-Aviv |
| 13:25-14:30 | Lunch and spontaneous discussions |
| 14:30 | End of the day |
Free registration for the Congress and the society
* By requesting to join the Israeli Society for Translational Medicine and participate in its activities, you agree to receive notifications from the society’s secretariat, including support offers for conference participation.
Abstract Submission Deadline:
August 1, 2025
Please register and submit abstracts for the first conference, which will be held on September 29, 2025, at Sourasky Medical Center in Tel Aviv.
We will strive to allow the presentation of a large number of abstracts so that we may become familiar with each other’s work.
Abstract guidelines:
- Please submit by August 1, 2025, at 12:00 noon.
- Up to 400 words and one figure or one table.
- Font: Times New Roman, size 12.
Best regards,
Dror Mevorach, President of the Society
Yigal Shoshan, Secretary
